feed,title,long_url,short_url
RS,Inverse agonist of ERRÎ³ controls influenza A virus and SARS-CoV-2 infections by targeting SREBP-1c-mediated fatty acid biosynthesis,https://www.researchsquare.com/article/rs-6651542/latest,
